Permanent pacemaker and implantable cardioverter defibrillator infections: Seven years of diagnostic and therapeutic experience of a single center

Clinical Cardiology

Volumn 33, Issue 7, 2010, Pages 406-411

  Cengiz, Mustafa ^a   Okutucu, Sercan ^a   Ascioglu, Sibel ^a   Şahin, Abdurrahman ^a   Aksoy, Hakan ^a   Deveci, Onur Sinan ^a   Kaya, Ergun Baris ^a   Aytemir, Kudret ^a   Kabakci, Giray ^a   Tokgozoglu, Lale ^a   Ozkutlu, Hilmi ^a   Oto, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; METICILLIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PROSTHESIS INFECTION; REIMPLANTATION; TERTIARY HEALTH CARE; ADOLESCENT; AGE; ANTIBIOTIC PROPHYLAXIS; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DEVICE REMOVAL; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MICROBIOLOGY; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RECURRENT DISEASE; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; TURKEY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 77954923024     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20765     Document Type: Article

References (29)

1. Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am. 2002;16:477-505, xii.
2. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167:669-75.
3. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147:582-586.
4. Camus C, Leport C, Raffi F, et al. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis. 1993;17:46-55. (Pubitemid 23197564)
5. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95:2098-2107. (Pubitemid 27184278)
6. Gandelman G, Frishman WH, Wiese C, et al. Intravascular device infections: epidemiology, diagnosis, andmanagement. Cardiol Rev. 2007;15:13-23.
7. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.Ann Intern Med. 2000;133:604-608.
8. Lewis AB, Hayes DL, Holmes DR Jr, et al. Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg. 1985;89:758-763.
9. Bracker F. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart. 2001;85:254-259.
10. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol. 1998;82:480-484.
11. Klug D, Balde M, Pavin D, et al; for PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349-1355.
12. Del Río A, Anguera I, Miŕo JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest. 2003;124:1451-1459.
13. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
14. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48:590-591.
15. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg. 1975;69:1-7.
16. Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl. 1985;699:1-62.
17. Catanchin A, Murdock CJ, Athan E. Pacemaker infections: a 10-year experience. Heart Lung Circ. 2007;16:434-439.
18. Mounsey JP, Griffith MJ, Tynan M, et al. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J. 1994;72:339-343. (Pubitemid 24322945)
19. Léon AR, Abraham WT, Curtis AB, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol. 2005;46: 2348-2356.
20. Duval X, Selton-Suty C, Alla F, et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis. 2004;39:68-74.
21. Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart. 2009;95:715-720.
22. Kleemann T, Becker T, Strauss M, et al. Prevalence of bacterial colonization of generator pockets in implantable cardioverter defibrillator patients without signs of infection undergoing generator replacement or lead revision. Europace. 2010;12:58-63.
23. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108: 2015-2031.
24. Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45:166-173. (Pubitemid 47041006)
25. Bertaglia E, Zerbo F, Zardo S, Barzan D, Zoppo F, Pascotto P. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: incidence of long-term infective complications. Pacing Clin Electrophysiol. 2006;29:29-33.
26. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J. 2005;51:461-470. (Pubitemid 41076784)
27. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97:1796-1801.
28. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62.
29. Daniel WG, M̈ugge A. Transesophageal echocardiography.N Engl J Med. 1995;332:1268-1279.